The properties of TREM1 and its emerging role in pain-related diseases
Authors:
Open Access
- 26 February 2025
- journal article
- review article
- Published by Springer Nature in Molecular Brain
- Vol. 18 (1) , 1-12
Abstract
The TREM1 receptor, a member of the TREMs family, is expressed by myeloid cells and functions as an initiator or enhancer of the inflammatory response, playing a pivotal role in the regulation of inflammation. In recent years, it has been found that TREM1-mediated inflammatory response is involved in the regulation of pain-related diseases. This article provides an extensive review on the structural characteristics and distribution patterns, ligand, signaling pathways, inhibitors, and pathophysiological roles of TREM1 in pain disorders aiming to further elucidate its biological function and offer novel insights for clinical interventions targeting pain-related diseases.Keywords
Funding Information
- The Provincial Education Department of Gansu (2022B-054, 2020-0411-SFC-0025)
- Lanzhou University Second Hospital (YJS-BD-05, CY2021-QN-B06, CYXZ2022-03)
This publication has 117 references indexed in Scilit:
- A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine SepsisJournal of Experimental Medicine, 2004
- Crystal Structure of Human Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) at 1.47ÅJournal of Molecular Biology, 2004
- Triggering Receptor Expressed on Myeloid Cells-1 in Neutrophil Inflammatory Responses: Differential Regulation of Activation and SurvivalThe Journal of Immunology, 2004
- Mycobacterium bovisBCG Cell Wall-Specific Differentially Expressed Genes Identified by Differential Display and cDNA Subtraction in Human MacrophagesInfection and Immunity, 2004
- TREMs in the immune system and beyondNature Reviews Immunology, 2003
- A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune ResponseThe Journal of Immunology, 2003
- Role of DAP12 in Innate and Adaptive Immune ResponsesCurrent Pharmaceutical Design, 2003
- TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid developmentMolecular Immunology, 2002
- Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and MonocytesThe Journal of Immunology, 2000
- The Extracellular Actin-Scavenger System and Actin ToxicityNew England Journal of Medicine, 1992